Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dopamine D2L receptor is a G protein-coupled receptor isoform encoded by the *DRD2* gene. It is predominantly postsynaptic and highly expressed in the striatum. Activation of D2L receptors leads to inhibition of adenylyl cyclase and decreased cAMP levels, playing a key role in motor control, reward processing, learning, and memory. It is a major target for antipsychotic drugs, and its dysfunction is implicated in neuropsychiatric disorders like schizophrenia and affective disorders.
Gi/o protein-coupled receptor agonist; inhibits adenylyl cyclase/cAMP production
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine D2L Receptor (D2L receptor).